Abstract:Importance: National guidelines allow consideration of postoperative radiation therapy (PORT) among patients with incompletely resected non-small cell lung cancer (NSCLC). However, there is a paucity of prospective data because recently completed trials excluded patients with positive surgical margins. In addition, unlike for locally advanced NSCLC, the role of intensity-modulated radiation therapy (IMRT) for PORT remains unclear. Objective: To evaluate trends of IMRT use for PORT in the US and the association of IMRT with survival outcomes among patients with incompletely resected NSCLC. Design, setting, and participants: This retrospective cohort study used data from the National Cancer Database for patients diagnosed between January 2004 and December 2019 with incompletely resected NSCLC who underwent upfront surgery with positive surgical margins followed by PORT. Exposures: IMRT vs 3D conformal radiation therapy (3DCRT) for PORT. Main outcomes and measures: The main outcome was overall survival. Multivariable Cox proportional hazards regression assessed the association of IMRT vs 3DCRT with overall survival. Multivariable logistic regression identified variables associated with IMRT. Propensity score matching (1:1) was performed based on variables of interest. Results: A total of 4483 patients (2439 men [54.4%]; median age, 67 years [IQR, 60-73 years]) were included in the analysis. Of those, 2116 (47.2%) underwent 3DCRT and 2367 (52.8%) underwent IMRT. Median follow-up was 48.5 months (IQR, 31.1-77.2 months). The proportion of patients who underwent IMRT increased from 14.3% (13 of 91 patients) in 2004 to 70.7% (33 of 471 patients) in 2019 (P < .001). IMRT was associated with improved overall survival compared with 3DCRT (adjusted hazard ratio, 0.84; 95% CI, 0.78-0.91; P < .001). Similar findings were observed for 1463 propensity score-matched pairs; IMRT was associated with improved 5-year overall survival compared with 3DCRT (37.3% vs 32.2%; hazard ratio, 0.88; 95% CI, 0.80-0.96; P = .003). IMRT use was associated with receipt of treatment at an academic facility (adjusted odds ratio [aOR], 1.15; 95% CI, 1.00-1.33; P = .049), having T4 stage tumors (aOR, 1.50; 95% CI, 1.13-1.99; P = .005) or N2 or N3 stage tumors (aOR, 1.25; 95% CI, 1.04-1.51; P = .02), and receipt of pneumonectomy (aOR, 1.35; 95% CI, 1.02-1.80; P = .04). Conclusion and relevance: This cohort study found that use of IMRT for PORT among patients with incompletely resected NSCLC increased in the US from 2004 to 2019 and was associated with improved survival compared with 3DCRT. Further studies are warranted to investigate the role of different radiation therapy techniques for PORT.

Prognostic impact of solid tumor component diameter in early-stage non-small cell lung carcinoma treated with intensity-modulated fractionated radiotherapy: a retrospective analysis impact of solid tumor component diameter in NSCLC treated with IMRT

Prognostic impact based on tumor diameter of pathological N1 lymph node metastases for non-small cell lung cancer

Meta-analysis of Comparing Part-Solid and Pure-Solid Tumors in Patients with Clinical Stage IA Non-Small-cell Lung Cancer in the Eighth Edition TNM Classification

Tumor volume impact on patient prognosis with locally advanced non-small-cell lung cancer treated by three-dimensional conformal radiation therapy

Tumor Size As a Predictor for Prognosis of Patients with Surgical IIIA-N2 Non-Small Cell Lung Cancer after Surgery.

Oncologic Outcomes of Patients with Resected T3N0M0 Non-small Cell Lung Cancer

Clinical T1aN0M0 Lung Cancer: Differences in Clinicopathological Patterns and Oncological Outcomes Based on the Findings on High-Resolution Computed Tomography

Prognosis Factors of Pathological Stage I Non-Small Cell Lung Cancer

Effect of Total Dose and Fraction Size on Survival of Patients with Locally Recurrent Nasopharyngeal Carcinoma Treated with Intensity‐modulated Radiotherapy: A Phase 2, Single‐center, Randomized Controlled Trial

Multimodal Treatment in Operable Stage III Non-Small Cell Lung Cancer Using the New TNM Staging Classification Version 8: Long Term Results of a Pooled Analysis of Three SAKK Trials

The Study of Tumor Volume As a Prognostic Factor in T Staging System for Non-Small Cell Lung Cancer: an Exploratory Study.

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Incidence of Small Lymph Node Metastases in Patients with Nasopharyngeal Carcinoma: Clinical Implications for Prognosis and Treatment

Solid component and tumor size correlate with prognosis of stage IB lung adenocarcinoma.

Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non-Small Cell Lung Cancer

Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm

Prognostic Value of Tumor Parameters Measured by MRI in Cervical Cancer Patients Receiving CCRT.

Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules

P1.03-084 Implications of 8th Edition TNM Proposal: Invasive Vs. Total Size for T Descriptor in Pt1a-2Bn0m0 Lung Adenocarcinoma

Treatment of Clinical T4 Stage Superior Sulcus Non-Small Cell Lung Cancer: a Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.

The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer